Skip to main content
IC
C&R Research Inc. (KOSDAQ:359090)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,059.00
-8.00 (-0.75%)
Last updated: May 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '23 Dec '22 Dec '21
Clinical Trials for Licensing
37.00B
Log In
Log In
Clinical Trials for Licensing Growth
13.10%
Log In
Log In
Non-licensed Clinical Trials
12.12B
Log In
Log In
Non-licensed Clinical Trials Growth
19.81%
Log In
Log In
Other Service
5.97B
Log In
Log In
Other Service Growth
8.15%
Log In
Log In
Rental
12.00M
Log In
Log In
Rental Growth
-91.84%
Log In
Log In
Services
-
Log In
Log In
Delivery
-
Log In
Log In
Goods
-
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '23 Dec '22 Dec '21
South Korea
54.84B
Log In
Log In
South Korea Growth
15.63%
Log In
Log In
Overseas
264.83M
Log In
Log In
Overseas Growth
-75.38%
Log In
Log In